Gastritis - Revision history

Ostermayer: Prepared the page for translation

2026-01-04T22:55:55Z

Prepared the page for translation

← Older revision		Revision as of 22:55, 4 January 2026
Line 1:		Line 1:
			<languages/>
			<translate>

	==Background==		==Background==

	[[File:Gray1046.png\|thumb\|Stomach anatomy]]		[[File:Gray1046.png\|thumb\|Stomach anatomy]]
	[[File:Illu stomach2.jpg\|thumb\|Stomach wall anatomy]]		[[File:Illu stomach2.jpg\|thumb\|Stomach wall anatomy]]
	*Inflammation of the stomach lining		*Inflammation of the stomach lining
	*May occur acutely or chronically		*May occur acutely or chronically
	*May lead to [[peptic ulcer disease]]		*May lead to [[Special:MyLanguage/peptic ulcer disease\|peptic ulcer disease]]
	*Causes		*Causes
	**[[H. pylori]]		**[[Special:MyLanguage/H. pylori\|H. pylori]]
	**[[NSAIDs]]		**[[Special:MyLanguage/NSAIDs\|NSAIDs]]
	**[[ETOH]]		**[[Special:MyLanguage/ETOH\|ETOH]]
	**Critical Illness (Cushing ulcer)		**Critical Illness (Cushing ulcer)
	***[[Increased ICP]], stimulation of vagal nuclei, increased secretion of gastric acid		***[[Special:MyLanguage/Increased ICP\|Increased ICP]], stimulation of vagal nuclei, increased secretion of gastric acid


	==Clinical Features==		==Clinical Features==
	*Gnawing or burning [[epigastric pain]]
	*[[Nausea/vomiting]]		*Gnawing or burning [[Special:MyLanguage/epigastric pain\|epigastric pain]]
			*[[Special:MyLanguage/Nausea/vomiting\|Nausea/vomiting]]
	*Early satiety, bloating		*Early satiety, bloating
	*Heartburn		*Heartburn


	==Differential Diagnosis==		==Differential Diagnosis==

			</translate>
	{{Abdominal Pain DDX Epigastric}}		{{Abdominal Pain DDX Epigastric}}
			<translate>


	==Evaluation==		==Evaluation==

	[[File:PMC5316417 10120 2016 680 Fig4 HTML.png\|thumb\|Conventional white-light endoscopic findings for the gastric body. (a) Normal (b) Gastric mucosa with chronic atrophic gastritis associated with HP infection. Visible vessels and an absence of folds in the gastric body mucosa are characteristic of chronic atrophic gastritis.]]		[[File:PMC5316417 10120 2016 680 Fig4 HTML.png\|thumb\|Conventional white-light endoscopic findings for the gastric body. (a) Normal (b) Gastric mucosa with chronic atrophic gastritis associated with HP infection. Visible vessels and an absence of folds in the gastric body mucosa are characteristic of chronic atrophic gastritis.]]
	*CBC (to rule out anemia)		*CBC (to rule out anemia)
	*BMP, [[LFTs]]		*BMP, [[Special:MyLanguage/LFTs\|LFTs]]
	*Lipase		*Lipase
	*Consider:		*Consider:
	**[[Acute abdominal series]]		**[[Special:MyLanguage/Acute abdominal series\|Acute abdominal series]]
	**?Barium swallow (upper GI series)		**?Barium swallow (upper GI series)
	**Endoscopy (most will be done as outpatient)		**Endoscopy (most will be done as outpatient)
	**[[RUQ US]]		**[[Special:MyLanguage/RUQ US\|RUQ US]]
	**[[ECG]]/[[troponin]]		**[[Special:MyLanguage/ECG\|ECG]]/[[Special:MyLanguage/troponin\|troponin]]


	==Management==		==Management==
	*Cessation of [[NSAIDs]] and [[ETOH]]
	*Eradicate [[H. pylori]] if identified in symptomatic patient
	**Triple Therapy: [[PPI]] + [[clarithromycin]] 500mg BID + [[amoxicillin]]1g BID x 10-14d
	***[[Metronidazole]] 500mg BID can be substituted for [[amoxicillin]] in penicillin-allergic individuals
	**Quadruple Therapy: [[PPI]] + [[bismuth subsalicylate]] 524mg QID + [[metronidazole]] 250mg QID and [[tetracycline]] 500mg QID x 10-14d.
	***Can be used in areas of high resistance to [[clarithromycin]] or [[metronidazole]]

	*[[PPI]]		*Cessation of [[Special:MyLanguage/NSAIDs\|NSAIDs]] and [[Special:MyLanguage/ETOH\|ETOH]]
	**Generally heal ulcers faster than [[H2 blocker]]s		*Eradicate [[Special:MyLanguage/H. pylori\|H. pylori]] if identified in symptomatic patient
	**[[Omeprazole]] 20-40mg QD		**Triple Therapy: [[Special:MyLanguage/PPI\|PPI]] + [[Special:MyLanguage/clarithromycin\|clarithromycin]] 500mg BID + [[Special:MyLanguage/amoxicillin\|amoxicillin]]1g BID x 10-14d
	*[[H2 blocker]]s		***[[Special:MyLanguage/Metronidazole\|Metronidazole]] 500mg BID can be substituted for [[Special:MyLanguage/amoxicillin\|amoxicillin]] in penicillin-allergic individuals
	**[[Famotidine]] 20-40mg QD		**Quadruple Therapy: [[Special:MyLanguage/PPI\|PPI]] + [[Special:MyLanguage/bismuth subsalicylate\|bismuth subsalicylate]] 524mg QID + [[Special:MyLanguage/metronidazole\|metronidazole]] 250mg QID and [[Special:MyLanguage/tetracycline\|tetracycline]] 500mg QID x 10-14d.
	**[[Ranitidine]] 75-150mg BID		***Can be used in areas of high resistance to [[Special:MyLanguage/clarithromycin\|clarithromycin]] or [[Special:MyLanguage/metronidazole\|metronidazole]]

			*[[Special:MyLanguage/PPI\|PPI]]
			**Generally heal ulcers faster than [[Special:MyLanguage/H2 blocker\|H2 blocker]]s
			**[[Special:MyLanguage/Omeprazole\|Omeprazole]] 20-40mg QD
			*[[Special:MyLanguage/H2 blocker\|H2 blocker]]s
			**[[Special:MyLanguage/Famotidine\|Famotidine]] 20-40mg QD
			**[[Special:MyLanguage/Ranitidine\|Ranitidine]] 75-150mg BID


	==Disposition==		==Disposition==

	*Normally outpatient management, unless complication (see below)		*Normally outpatient management, unless complication (see below)


	===Red Flags===		===Red Flags===

	Any of the following suggest need for endoscopy referral:		Any of the following suggest need for endoscopy referral:
	*Age >55yr		*Age >55yr
	*Unexplained weight loss		*Unexplained weight loss
	*Early satiety		*Early satiety
	*Persistent [[vomiting]]		*Persistent [[Special:MyLanguage/vomiting\|vomiting]]
	*[[Dysphagia]]		*[[Special:MyLanguage/Dysphagia\|Dysphagia]]
	*[[Anemia]] or [[GI bleeding]]		*[[Special:MyLanguage/Anemia\|Anemia]] or [[Special:MyLanguage/GI bleeding\|GI bleeding]]
	*Abdominal mass		*Abdominal mass
	*Persistent anorexia		*Persistent anorexia
	*[[Jaundice]]		*[[Special:MyLanguage/Jaundice\|Jaundice]]


	==See Also==		==See Also==
	*[[PUD]]
			*[[Special:MyLanguage/PUD\|PUD]]


	==References==		==References==

	<references/>		<references/>

	[[Category:GI]]		[[Category:GI]]
			</translate>

Rossdonaldson1: /* See Also */

2020-05-02T13:34:14Z

Rossdonaldson1: /* Evaluation */

2020-05-02T13:33:46Z

Evaluation

← Older revision		Revision as of 13:33, 2 May 2020
Line 22:		Line 22:

	==Evaluation==		==Evaluation==
	[[File:PMC5316417 10120 2016 680 Fig4 HTML.png\|thumb\|Conventional white-light endoscopic findings for the gastric body. (a) Normal ~~gastric mucosa without HP infection.~~ (b) Gastric mucosa with chronic atrophic gastritis associated with HP infection. Visible vessels and an absence of folds in the gastric body mucosa are characteristic of chronic atrophic gastritis.]]		[[File:PMC5316417 10120 2016 680 Fig4 HTML.png\|thumb\|Conventional white-light endoscopic findings for the gastric body. (a) Normal (b) Gastric mucosa with chronic atrophic gastritis associated with HP infection. Visible vessels and an absence of folds in the gastric body mucosa are characteristic of chronic atrophic gastritis.]]
	*CBC (to rule out anemia)		*CBC (to rule out anemia)
	*BMP, [[LFTs]]		*BMP, [[LFTs]]

Rossdonaldson1: /* Evaluation */

2020-05-02T13:32:50Z

Evaluation

← Older revision		Revision as of 13:32, 2 May 2020
Line 22:		Line 22:

	==Evaluation==		==Evaluation==
			[[File:PMC5316417 10120 2016 680 Fig4 HTML.png\|thumb\|Conventional white-light endoscopic findings for the gastric body. (a) Normal gastric mucosa without HP infection. (b) Gastric mucosa with chronic atrophic gastritis associated with HP infection. Visible vessels and an absence of folds in the gastric body mucosa are characteristic of chronic atrophic gastritis.]]
	*CBC (to rule out anemia)		*CBC (to rule out anemia)
	*BMP, [[LFTs]]		*BMP, [[LFTs]]

Rossdonaldson1: /* Differential Diagnosis */

2020-05-02T13:25:31Z

Differential Diagnosis

@@ Line 19: / Line 19: @@
 ==Differential Diagnosis==
-===[[Epigastric pain|Epigastric Pain]]===
+{{Abdominal Pain DDX Epigastric}}
 ==Evaluation==

Rossdonaldson1: /* Epigastric Pain */

2020-05-02T13:23:11Z

Epigastric Pain

← Older revision		Revision as of 13:23, 2 May 2020
Line 30:		Line 30:
	**[[Acalculous cholecystitis]]		**[[Acalculous cholecystitis]]
	*[[Myocardial Ischemia]]		*[[Myocardial Ischemia]]
	*[[Splenic ~~onfarction~~]]/enlargement/rupture/aneurysm		*[[Splenic infarction]]/enlargement/rupture/aneurysm
	*[[Pericarditis]]/[[Myocarditis]]		*[[Pericarditis]]/[[Myocarditis]]
	*[[Aortic Dissection]]		*[[Aortic Dissection]]

Rossdonaldson1: /* Epigastric Pain */

2020-05-02T13:22:55Z

Epigastric Pain

← Older revision		Revision as of 13:22, 2 May 2020
Line 30:		Line 30:
	**[[Acalculous cholecystitis]]		**[[Acalculous cholecystitis]]
	*[[Myocardial Ischemia]]		*[[Myocardial Ischemia]]
	*[[Splenic ~~Infarction~~]]enlargement/rupture/aneurysm		*[[Splenic onfarction]]/enlargement/rupture/aneurysm
	*[[Pericarditis]]/[[Myocarditis]]		*[[Pericarditis]]/[[Myocarditis]]
	*[[Aortic Dissection]]		*[[Aortic Dissection]]

Rossdonaldson1: /* Background */

2020-05-02T13:22:11Z

Background

← Older revision		Revision as of 13:22, 2 May 2020
Line 1:		Line 1:
	==Background==		==Background==
			[[File:Gray1046.png\|thumb\|Stomach anatomy]]
			[[File:Illu stomach2.jpg\|thumb\|Stomach wall anatomy]]
	*Inflammation of the stomach lining		*Inflammation of the stomach lining
	*May occur acutely or chronically		*May occur acutely or chronically

ClaireLewis at 20:49, 29 September 2019

2019-09-29T20:49:52Z

← Older revision		Revision as of 20:49, 29 September 2019
Line 45:		Line 45:
	*Lipase		*Lipase
	*Consider:		*Consider:
	**Acute abdominal series		**[[Acute abdominal series]]
	**?Barium swallow (upper GI series)		**?Barium swallow (upper GI series)
	**~~endoscopy~~ (most will be done as outpatient)		**Endoscopy (most will be done as outpatient)
	**[[RUQ US]]		**[[RUQ US]]
	**[[ECG]]/[[troponin]]		**[[ECG]]/[[troponin]]
Line 62:		Line 62:
	**Generally heal ulcers faster than [[H2 blocker]]s		**Generally heal ulcers faster than [[H2 blocker]]s
	**[[Omeprazole]] 20-40mg QD		**[[Omeprazole]] 20-40mg QD
	*[[H2 ~~Blocker~~]]s		*[[H2 blocker]]s
	**[[Famotidine]] 20-40mg QD		**[[Famotidine]] 20-40mg QD
	**[[Ranitidine]] 75-150mg BID		**[[Ranitidine]] 75-150mg BID

ClaireLewis at 15:15, 14 September 2019

2019-09-14T15:15:24Z

← Older revision		Revision as of 15:15, 14 September 2019
Line 4:		Line 4:
	*May lead to [[peptic ulcer disease]]		*May lead to [[peptic ulcer disease]]
	*Causes		*Causes
	**H. pylori		**[[H. pylori]]
	**NSAIDs		**[[NSAIDs]]
	**ETOH		**[[ETOH]]
	**Critical Illness (Cushing ulcer)		**Critical Illness (Cushing ulcer)
	***Increased ICP, stimulation of vagal nuclei, increased secretion of gastric acid		***[[Increased ICP]], stimulation of vagal nuclei, increased secretion of gastric acid

	==Clinical Features==		==Clinical Features==
	*Gnawing or burning pain ~~in epigastric area~~		*Gnawing or burning [[epigastric pain]]
	*Nausea, vomiting		*[[Nausea/vomiting]]
	*Early satiety, bloating		*Early satiety, bloating
	*Heartburn		*Heartburn
Line 36:		Line 36:
	*[[Pyogenic liver abscess]]		*[[Pyogenic liver abscess]]
	*[[Fitz-Hugh-Curtis Syndrome]]		*[[Fitz-Hugh-Curtis Syndrome]]
	*Hepatomegaly due to [[CHF]]		*[[Hepatomegaly]] due to [[CHF]]
	*[[Bowel obstruction]]		*[[Bowel obstruction]]
	*[[Pulmonary embolism]]		*[[Pulmonary embolism]]
Line 42:		Line 42:
	==Evaluation==		==Evaluation==
	*CBC (to rule out anemia)		*CBC (to rule out anemia)
	*BMP, LFTs		*BMP, [[LFTs]]
	*Lipase		*Lipase
	*Consider:		*Consider:
Line 48:		Line 48:
	**?Barium swallow (upper GI series)		**?Barium swallow (upper GI series)
	**endoscopy (most will be done as outpatient)		**endoscopy (most will be done as outpatient)
	**RUQ US		**[[RUQ US]]
	**[[ECG]]/troponin		**[[ECG]]/[[troponin]]

	==Management==		==Management==
	*Cessation of NSAIDs and ~~Etoh~~		*Cessation of [[NSAIDs]] and [[ETOH]]
	*Eradicate H. pylori if identified in symptomatic patient		*Eradicate [[H. pylori]] if identified in symptomatic patient
	**Triple Therapy: PPI + [[clarithromycin]] 500mg BID + [[amoxicillin]]1g BID x 10-14d		**Triple Therapy: [[PPI]] + [[clarithromycin]] 500mg BID + [[amoxicillin]]1g BID x 10-14d
	***[[Metronidazole]] 500mg BID can be substituted for [[amoxicillin]] in penicillin-allergic individuals		***[[Metronidazole]] 500mg BID can be substituted for [[amoxicillin]] in penicillin-allergic individuals
	**Quadruple Therapy: PPI + bismuth subsalicylate 524mg QID + [[metronidazole]] 250mg QID and [[tetracycline]] 500mg QID x 10-14d.		**Quadruple Therapy: [[PPI]] + [[bismuth subsalicylate]] 524mg QID + [[metronidazole]] 250mg QID and [[tetracycline]] 500mg QID x 10-14d.
	***Can be used in areas of high resistance to [[clarithromycin]] or metronidazole		***Can be used in areas of high resistance to [[clarithromycin]] or [[metronidazole]]

	*PPI		*[[PPI]]
	**Generally heal ulcers faster than H2 ~~blockers~~		**Generally heal ulcers faster than [[H2 blocker]]s
	**[[Omeprazole]] 20-40mg QD		**[[Omeprazole]] 20-40mg QD
	*H2 ~~Blockers~~		*[[H2 Blocker]]s
	**[[Famotidine]] 20-40mg QD		**[[Famotidine]] 20-40mg QD
	**[[Ranitidine]] 75-150mg BID		**[[Ranitidine]] 75-150mg BID
Line 74:		Line 74:
	*Unexplained weight loss		*Unexplained weight loss
	*Early satiety		*Early satiety
	*Persistent vomiting		*Persistent [[vomiting]]
	*Dysphagia		*[[Dysphagia]]
	*Anemia or GI bleeding		*[[Anemia]] or [[GI bleeding]]
	*Abdominal mass		*Abdominal mass
	*Persistent anorexia		*Persistent anorexia
	*Jaundice		*[[Jaundice]]

	==See Also==		==See Also==

← Older revision		Revision as of 13:34, 2 May 2020
Line 64:		Line 64:

	==See Also==		==See Also==
	[[PUD]]		*[[PUD]]

	==References==		==References==